ArticleJournal for immunotherapy of cancer2026

Optimizing anti-PI3Kδ and anti-LAG-3 immunotherapy dosing regimens in a mouse model of triple-negative breast cancer improves outcome by removing treatment-related adverse events.

Sarah Nicol Lauder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.